Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+4.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+4.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$2.70M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$2.19M-4.5%
2019$2.30M+19.7%
2018$1.92M+19.1%
2017$1.61M+6.7%
2016$1.51M-